Cargando…
Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212516/ http://dx.doi.org/10.1016/S0016-5085(22)61411-2 |
| _version_ | 1784730614821289984 |
|---|---|
| author | Schell, Trevor Knutson, Keith Saha, Sumona Wald, Arnold Phan, Hiep S. Almasry, Mazen Chun, Kelly Y. Grimes, Ian C. Lutz, Megan Hayney, Mary S. Farraye, Francis A. Caldera, Freddy |
| author_facet | Schell, Trevor Knutson, Keith Saha, Sumona Wald, Arnold Phan, Hiep S. Almasry, Mazen Chun, Kelly Y. Grimes, Ian C. Lutz, Megan Hayney, Mary S. Farraye, Francis A. Caldera, Freddy |
| author_sort | Schell, Trevor |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212516 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92125162022-06-22 Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Schell, Trevor Knutson, Keith Saha, Sumona Wald, Arnold Phan, Hiep S. Almasry, Mazen Chun, Kelly Y. Grimes, Ian C. Lutz, Megan Hayney, Mary S. Farraye, Francis A. Caldera, Freddy Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212516/ http://dx.doi.org/10.1016/S0016-5085(22)61411-2 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Schell, Trevor Knutson, Keith Saha, Sumona Wald, Arnold Phan, Hiep S. Almasry, Mazen Chun, Kelly Y. Grimes, Ian C. Lutz, Megan Hayney, Mary S. Farraye, Francis A. Caldera, Freddy Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title | Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_full | Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_fullStr | Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_full_unstemmed | Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_short | Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_sort | su1489: humoral immunogenicity of three sars-cov-2 mrna vaccine doses in patients with inflammatory bowel disease |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212516/ http://dx.doi.org/10.1016/S0016-5085(22)61411-2 |
| work_keys_str_mv | AT schelltrevor su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT knutsonkeith su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT sahasumona su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT waldarnold su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT phanhieps su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT almasrymazen su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT chunkellyy su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT grimesianc su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT lutzmegan su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT hayneymarys su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT farrayefrancisa su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease AT calderafreddy su1489humoralimmunogenicityofthreesarscov2mrnavaccinedosesinpatientswithinflammatoryboweldisease |